|
Volumn 65, Issue 2, 2011, Pages 420-421
|
Atenolol: A promising alternative to propranolol for the treatment of hemangiomas
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATENOLOL;
BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT;
BRONCHODILATING AGENT;
PROPRANOLOL;
BRONCHUS HYPERREACTIVITY;
CAPILLARY HEMANGIOMA;
CASE REPORT;
DRUG EFFECT;
DRUG SUBSTITUTION;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
EXCISION;
FOLLOW UP;
HEMANGIOMA;
HOSPITAL ADMISSION;
HUMAN;
HYPOTENSION;
INFANT;
LETTER;
MALE;
OXYGEN THERAPY;
PRIORITY JOURNAL;
SLEEP DISORDER;
TREATMENT INDICATION;
TREATMENT RESPONSE;
ULCERATING SACRAL HEMANGIOMA;
ATENOLOL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HEMANGIOMA;
HUMANS;
INFANT;
MALE;
PROPRANOLOL;
RISK ASSESSMENT;
SKIN NEOPLASMS;
TREATMENT OUTCOME;
|
EID: 79960409093
PISSN: 01909622
EISSN: 10976787
Source Type: Journal
DOI: 10.1016/j.jaad.2010.11.056 Document Type: Letter |
Times cited : (60)
|
References (7)
|